High-Throughput Assay for the Identification of Compounds Regulating Osteogenic Differentiation of Human Mesenchymal Stromal Cells
Osteoporosis and other bone-related disorders represent a major public health threat. One out of every two women and one in four men, aged 50 or older, is expected to develop an osteoporosis-related fracture in their lifetime [1], [2], [3]. There is a huge demand for products enhancing bone regeneration. Therefore, the last decade was denominated the bone and joint decade by the World Health Authority.